NCT06739902

Brief Summary

This study aims to evaluate the effectiveness of combining virtual reality (VR) therapy with traditional physiotherapy in post-stroke rehabilitation. Post-stroke patients often suffer from impairments in motor function, balance, and overall quality of life. While traditional physiotherapy is a widely accepted method for stroke recovery, incorporating VR technology may enhance treatment outcomes by providing an engaging, immersive environment that motivates patients to perform therapeutic movements.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 13, 2024

Last Update Submit

December 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Berg Balance Scale (BBS)

    Assesses balance and stability.- \*Purpose\*: Assesses balance in older adults and individuals with balance disorders. * \*Items\*: 14 tasks, such as sitting, standing, reaching, and turning. * \*Scoring\*: Each task is scored on a scale of 0-4 (0 = inability to perform the task, 4 = normal performance). * \*Total Score\*: The maximum score is 56. Higher scores indicate better balance. A score below 45 indicates a higher risk of falling.

    12 Months

  • Trunk Impairment Scale (TIS)

    Measures trunk control and stability. SF-12 Health Survey: Evaluates quality of life in physical and mental health domains.The \*Trunk Impairment Scale (TIS)\* is a clinical tool used to assess trunk performance in individuals, particularly those with neurological impairments like stroke. It measures three key aspects: \*static sitting balance, \*\*dynamic sitting balance, and \*\*coordination of trunk movements. The scale consists of \*\*17 items\*, with scores ranging from 0 to 23. Higher scores indicate better trunk control and stability. It helps clinicians evaluate and track improvements in trunk function over time, guiding rehabilitation interventions.

    12 Months

Study Arms (2)

Interventional group I

EXPERIMENTAL
Diagnostic Test: Traditional Physiotherapy Group

Interventional group II

ACTIVE COMPARATOR
Combination Product: VR + Traditional Physiotherapy Group

Interventions

Participants receive standard physiotherapy exercises aimed at improving motor function, balance, and trunk stability. These exercises include stretching, balance training, and muscle-strengthening activities.

Interventional group I

Participants receive the same physiotherapy exercises as the traditional group, but with additional sessions involving virtual reality exercises. The VR component includes immersive activities that stimulate motor control, coordination, and cognitive engagement to support functional recovery.

Interventional group II

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke, either ischemic or hemorrhagic
  • Participants who can ambulate independently or with minimal assistance.
  • Participants who were willing \& able to adhere to the study protocol.
  • Including participants who were attending follow-up appointments \& completing outcome measures.
  • Participants who were able to understand \& provide written informed consent

You may not qualify if:

  • Existence of additional neurological disorders (such as multiple sclerosis or Parkinson's disease) or serious medical conditions that could prevent participants from participating in the study.
  • Participants receiving rehabilitation or rigorous physical treatment in the previous three months were excluded.
  • Pregnant women or breastfeeding women.
  • Participants who refused to participate in the study or provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Services Hospital, Shadman 1

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 13, 2024

First Posted

December 18, 2024

Study Start

February 28, 2024

Primary Completion

August 1, 2024

Study Completion

March 1, 2025

Last Updated

December 18, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations